{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T10:54:33Z","timestamp":1788346473539,"version":"build-2803163510"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T00:00:00Z","timestamp":1376956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-230x-13-130","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T06:14:45Z","timestamp":1376979285000},"source":"Crossref","is-referenced-by-count":16,"title":["Treatment of children and adolescents with ulcerative colitis by adsorptive depletion of myeloid lineage leucocytes as monotherapy or in combination with low dose prednisolone after failure of first-line medications"],"prefix":"10.1186","volume":"13","author":[{"given":"Tomotaka","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Goishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Kajihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihisa","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,20]]},"reference":[{"key":"990_CR1","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK: Inflammatory bowel disease. N Engl J Med. 2002, 347: 417-419. 10.1056\/NEJMra020831.","journal-title":"N Engl J Med"},{"key":"990_CR2","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/00004836-199506000-00004","volume":"20","author":"A Kornbluth","year":"1995","unstructured":"Kornbluth A, Marion JF, Salomon P, Janowitz HD: How effective is current medical therapy for severe ulcerative colitis?. J Clin Gastroenterol. 1995, 20: 280-284. 10.1097\/00004836-199506000-00004.","journal-title":"J Clin Gastroenterol"},{"key":"990_CR3","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/BF01296907","volume":"28","author":"SL Taffet","year":"1983","unstructured":"Taffet SL, Das KM: Sulphasalazine-adverse effects and desensitization. Dig Dis Sci. 1983, 28: 833-842. 10.1007\/BF01296907.","journal-title":"Dig Dis Sci"},{"key":"990_CR4","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/00054725-200002000-00009","volume":"6","author":"DH Present","year":"2000","unstructured":"Present DH: How to do without steroids in inflammatory bowel disease. Inflamm Bowel Dis. 2000, 6: 48-57. 10.1097\/00054725-200002000-00009.","journal-title":"Inflamm Bowel Dis"},{"key":"990_CR5","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/S0140-6736(74)90552-2","volume":"1","author":"SC Truelove","year":"1974","unstructured":"Truelove SC, Jewell DP: Intensive intravenous regimens for severe attacks of ulcerative colitis. Lancet. 1974, 1: 1067-1070.","journal-title":"Lancet"},{"key":"990_CR6","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1159\/000336766","volume":"85","author":"J Ezri","year":"2012","unstructured":"Ezri J, Marques-Vidal P, Nydegger A: Impact of disease and treatments on growth and puberty of pediatric patients with inflammatory bowel disease. Digestion. 2012, 85: 308-3019. 10.1159\/000336766.","journal-title":"Digestion"},{"key":"990_CR7","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1002\/art.10679","volume":"46","author":"SL Brown","year":"2002","unstructured":"Brown SL, Greene MH, Gershon SK, Edwards ET, Mraun MM: Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum. 2002, 46: 3151-3158. 10.1002\/art.10679.","journal-title":"Arthritis Rheum"},{"key":"990_CR8","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/ibd.21871","volume":"18","author":"CI de Bie","year":"2012","unstructured":"de Bie CI, Escher JC, de Ridder L: Antitumor necrosis factor treatment for pediatric inflammatory bowel disease. Inflamm Bowel Dis. 2012, 18: 981-998.","journal-title":"Inflamm Bowel Dis"},{"key":"990_CR9","doi-asserted-by":"publisher","first-page":"3536","DOI":"10.4049\/jimmunol.168.7.3536","volume":"168","author":"KU Belge","year":"2002","unstructured":"Belge KU, Ziegler-Heitbrock HW: The proinflammatory CD14\u2009+\u2009CD16+ monocytes are a major source of TNF. J Immunol. 2002, 168: 3536-3542.","journal-title":"J Immunol"},{"key":"990_CR10","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1111\/j.1572-0241.2007.01714.x","volume":"103","author":"H Hanai","year":"2008","unstructured":"Hanai H, Iida T, Takeuchi K: Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease. Am J Gastroenterol. 2008, 103: 1210-1216. 10.1111\/j.1572-0241.2007.01714.x.","journal-title":"Am J Gastroenterol"},{"key":"990_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1111\/j.1365-2249.1991.tb02958.x","volume":"86","author":"DA McCarthy","year":"1991","unstructured":"McCarthy DA, Rampton DS, Liu Y-C: Peripheral blood neutrophils in inflammatory bowel disease: morphological evidence of in vivo activation in active disease. Clin Exp Immunol. 1991, 86: 489-493. 10.1111\/j.1365-2249.1991.tb02958.x.","journal-title":"Clin Exp Immunol"},{"key":"990_CR12","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1136\/gut.42.4.470","volume":"42","author":"S Nikolaus","year":"1998","unstructured":"Nikolaus S, Bauditz J, Gionchetti P: Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin-10 during intestinal inflammation. Gut. 1998, 42: 470-476. 10.1136\/gut.42.4.470.","journal-title":"Gut"},{"key":"990_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/gast.2000.8523","volume":"119","author":"JA Tibble","year":"2000","unstructured":"Tibble JA, Sigthorsson G, Bridger D, Fagerhol MK, Bjarnason I: Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000, 119: 15-22. 10.1053\/gast.2000.8523.","journal-title":"Gastroenterology"},{"key":"990_CR14","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1046\/j.1526-0968.2003.00012.x","volume":"7","author":"AR Saniabadi","year":"2003","unstructured":"Saniabadi AR, Hanai H, Sawada K, Adachi T, Bjarnason I, Lofberg R, et al: Adacolumn, an adsorptive carrier based granulocyte and monocyte apheresis device for the treatment of inflammatory and refractory diseases associated with leukocytes. Ther Apher Dial. 2003, 7: 48-59. 10.1046\/j.1526-0968.2003.00012.x.","journal-title":"Ther Apher Dial"},{"key":"990_CR15","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.transci.2007.08.003","volume":"37","author":"AR Saniabadi","year":"2007","unstructured":"Saniabadi AR, Hanai H, Fukunaga K, Sawada K, Bjarnason I, Lofberg R, et al: Therapeutic Leucocytapheresis for inflammatory bowel disease. Transf Apher Sci. 2007, 37: 191-200. 10.1016\/j.transci.2007.08.003.","journal-title":"Transf Apher Sci"},{"key":"990_CR16","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1007\/s10620-006-9560-z","volume":"52","author":"Y Yokoyama","year":"2007","unstructured":"Yokoyama Y, Fukunaga K, Fukuda Y, Tozawa K, Kamikozuru K, Ohnishi K, et al: Demonstration of low-regulatory CD25HighCD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis. Dig Dis Sci. 2007, 52: 2725-2731. 10.1007\/s10620-006-9560-z.","journal-title":"Dig Dis Sci"},{"key":"990_CR17","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.crohns.2011.12.009","volume":"6","author":"T Yamamoto","year":"2012","unstructured":"Yamamoto T, Umegae S, Matsumoto K: Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis. J Crohn\u2019s Colitis. 2012, 6: 750-755. 10.1016\/j.crohns.2011.12.009.","journal-title":"J Crohn\u2019s Colitis"},{"key":"990_CR18","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/j.1365-2036.2004.02288.x","volume":"20","author":"E Domenech","year":"2004","unstructured":"Domenech E, Hinojosa J, Esteve-Comas M: Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study. Aliment Pharmacol Ther. 2004, 20: 1347-1352. 10.1111\/j.1365-2036.2004.02288.x.","journal-title":"Aliment Pharmacol Ther"},{"key":"990_CR19","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.dld.2007.02.003","volume":"39","author":"R Caprilli","year":"2007","unstructured":"Caprilli R, D'Ovidio V: Leukocytapheresis as promising therapy for inflammatory bowel disease. Dig Liver Dis. 2007, 39: 435-437. 10.1016\/j.dld.2007.02.003.","journal-title":"Dig Liver Dis"},{"key":"990_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.dld.2007.03.007","volume":"39","author":"J Pan\u00e9s","year":"2007","unstructured":"Pan\u00e9s J, Guilera M, Ginard D, Hinojosa J, Gonz\u00e1lez-Carro P, Gonz\u00e1lez-Lara V, et al: Treatment cost of ulcerative colitis is apheresis with Adacolumn cost-effective?. Dig Liver Dis. 2007, 39: 617-625. 10.1016\/j.dld.2007.03.007.","journal-title":"Dig Liver Dis"},{"key":"990_CR21","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1002\/ibd.20505","volume":"14","author":"L Maiden","year":"2008","unstructured":"Maiden L, Takeuchi K, Bjarnason I, et al: Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse. Inflamm Bowel Dis. 2008, 14: 1413-1418. 10.1002\/ibd.20505.","journal-title":"Inflamm Bowel Dis"},{"key":"990_CR22","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.dld.2007.01.001","volume":"39","author":"G Bresci","year":"2007","unstructured":"Bresci G, Parisi G, Mazzoni A, Scatena F, Capria A: Treatment of patients with acute ulcerative colitis: conventional corticosteroid therapy (MP) versus granulocytapheresis (GMA): a pilot study. Dig Liver Dis. 2007, 39: 430-434. 10.1016\/j.dld.2007.01.001.","journal-title":"Dig Liver Dis"},{"key":"990_CR23","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"Rachmilewitz D on behalf of an international study group","year":"1989","unstructured":"Rachmilewitz D on behalf of an international study group: Coated mesalazine (5-aminisalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. Br Med J. 1989, 298: 82-86. 10.1136\/bmj.298.6666.82.","journal-title":"Br Med J"},{"key":"990_CR24","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1016\/0016-5085(87)90621-4","volume":"92","author":"LR Sutherland","year":"1987","unstructured":"Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, et al: 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. Gastroenterology. 1987, 92: 1894-1898.","journal-title":"Gastroenterology"},{"key":"990_CR25","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.gcb.2010.08.007","volume":"34","author":"T Tanaka","year":"2010","unstructured":"Tanaka T, Okanobu H, Kuga Y, Yoshifuku Y, Fujino H, Miwata T, et al: Clinical and endoscopic features of responders and non-responders to adsorptive leucocytapheresis: a report based on 120 patients with active ulcerative colitis. Gastroenterol Clin Biol. 2010, 34: 687-695. 10.1016\/j.gcb.2010.08.007.","journal-title":"Gastroenterol Clin Biol"},{"key":"990_CR26","unstructured":"Kashiwagi N, Saniabadi A, Shimoyama T: Immunomodulatory effects of granulocyte and monocyte adsorption apheresis as a treatment for patients with ulcerative colitis. Dig Dis Sci. 2002, 1334-1341. 47"},{"key":"990_CR27","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1023\/B:DDAS.0000026299.43792.ae","volume":"49","author":"Y Suzuki","year":"2004","unstructured":"Suzuki Y, Yoshimura N, Saniabadi AR, Saito Y: Selective neutrophil and monocyte adsorptive apheresis as a first line treatment for steroid na\u00efve patients with active ulcerative colitis: a prospective uncontrolled study. Dig Dis Sci. 2004, 49: 565-571.","journal-title":"Dig Dis Sci"},{"key":"990_CR28","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.dld.2008.02.012","volume":"40","author":"T Tanaka","year":"2008","unstructured":"Tanaka T, Okanobu H, Yoshimi S, Murakami E, Kogame A, Imagawa H, et al: Adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid na\u00efve patients. Dig Liver Dis. 2008, 40: 731-736. 10.1016\/j.dld.2008.02.012.","journal-title":"Dig Liver Dis"},{"key":"990_CR29","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1053\/j.gastro.2008.04.023","volume":"135","author":"BE Sands","year":"2008","unstructured":"Sands BE, Sandborn WJ, Feagan B, L\u00f6fberg R, Hibi T, Wang T, et al: A randomized, double-blind, sham-controlled study of granulocyte\/monocyte apheresis for active ulcerative colitis. Gastroenterology. 2008, 135: 400-409. 10.1053\/j.gastro.2008.04.023.","journal-title":"Gastroenterology"},{"key":"990_CR30","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1007\/s10620-006-9199-9","volume":"51","author":"Y Suzuki","year":"2006","unstructured":"Suzuki Y, Yoshimura N, Saito Y, Saniabadi A: A retrospective search for predictors of clinical response to selective granulocyte and monocyte apheresis in patients with ulcerative colitis. Dig Dis Sci. 2006, 51: 2031-2038. 10.1007\/s10620-006-9199-9.","journal-title":"Dig Dis Sci"},{"key":"990_CR31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1471-230X-13-27","volume":"13","author":"Y Yokoyama","year":"2013","unstructured":"Yokoyama Y, Kawai M, Fukunaga K, Kamikozuru K, Nagase K, Nogami K, et al: Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA. BMC Gastroenterol. 2013, 13: 27-10.1186\/1471-230X-13-27.","journal-title":"BMC Gastroenterol"},{"key":"990_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/apt.12102","volume":"37","author":"JF Mayberry","year":"2013","unstructured":"Mayberry JF, Lobo A, Ford AC, Thomas A: On behalf of the Guideline Development Group. NICE clinical guideline (CG152): the management of Crohn's disease in adults, children and young people. Aliment Pharmacol Ther. 2013, 37: 195-203. 10.1111\/apt.12102.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-13-130\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-13-130.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T03:47:57Z","timestamp":1548128877000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-13-130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,20]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["990"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-13-130","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,20]]},"article-number":"130"}}